Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42.
Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42.
复制标题
DOI:
10.1158/0008-5472.can-08-0131
复制
发表时间:
2008-10-15
期刊:
影响因子:
11.2
通讯作者:
Chen CY
中科院分区:
文献类型:
--
作者:
Guo J;Ibaragi S;Zhu T;Luo LY;Hu GF;Huppi PS;Chen CY
Nicotine, one of major components in tobacco, has been shown to be at high concentrations in the blood stream of cigarette smokers. However, the mechanisms of how nicotine affects tumor development and whether nicotine is a potential carcinogen for malignancies induced by second-hand smoking are not fully understood yet. Here, we investigate the signaling pathways by which nicotine potentiates tumorigenesis in human mammary epithelial-like MCF10A or cancerous MCF7 cells. We demonstrate that human MCF10A and MCF7 cells both express four subunits of nAChR. The treatment of these cells with nicotine enhances the activity of protein kinase C (PKC) α without altering the expression level of this kinase. Nicotine also stimulates [3H]thymidine incorporation into the genome of these cells as well as forces serum-starved cells to enter S phase of the cell cycle, resulting of growth promotion. Importantly, upon nicotine treatment, the mobility of MCF10A and MCF7 cells are enhanced, which can be blocked by the addition of nAChR or PKC inhibitor. Experiments using siRNA knockdown or ectopic expression of cdc42 demonstrated that cdc42 functions as a downstream effector of PKC and is crucial in the regulation of nicotine-mediated migratory activity in the cells. Together, our findings suggest that nicotine, through interacting with its receptor, initiates a signaling cascade that involves PKC and cdc42, and consequently promotes migration in mammary epithelial or tumor cells.